Dawn Newmin's Colleagues at Trevi Therapeutics
Dawn Newmin's Contact Details
HQ
203-304-2499
203-304-2499
Location
Bristol, Connecticut, United States
Bristol, Connecticut, United States
Company
Trevi Therapeutics
Trevi Therapeutics
Dawn Newmin's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Dawn Newmin
Dawn Newmin currently works for Trevi Therapeutics.
Dawn Newmin's role at Trevi Therapeutics is Clinical Operations Specialist.
Dawn Newmin's email address is ***@trevitherapeutics.com. To view Dawn Newmin's full email address, please signup to ConnectPlex.
Dawn Newmin works in the BioTech/Drugs industry.
Dawn Newmin's colleagues at Trevi Therapeutics are Katie McManus, Lauren Waggoner Kriss, Lori Iwanicki, Lara Lewkowicz, Rebecca Morse, Jim Cassella, Anne VanLent and others.
Dawn Newmin's phone number is 203-304-2499